GERN Jun 2024 3.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:42AM EDT. Market open.
Loading interactive chart…
- Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif., June 20, 2024--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 222,660 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.
- Simply Wall St.
Geron Corporation's (NASDAQ:GERN) large institutional owners must be happy as stock continues to impress, up 27% over the past week
Key Insights Institutions' substantial holdings in Geron implies that they have significant influence over the...
- Zacks
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Geron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the treatment of adult patients with lower-risk MDS with transfusion-dependent anemia.
© 2024 Yahoo. All rights reserved.